Thursday, July 15, 2010

Arsenic: New TNBC Treatment?

Arsenic trioxide combined with nanotechnology might provide the double whammy that can fight triple negative breast cancers, say researchers at Northwestern University. Arsenic has been effective against blood cancers but not against solid tumors because it flushes through the blood stream too quickly. An arsenic nanoparticle, however, was successful in targeting TNBC in mice, causing cancer cells to die. Read more at Genetic Engineering and Biotechnology News.

No comments: